Jian Zhen Lin

Profusa, Inc. provides biofeedback for chronic disease management and healthy livingg. It develops an in vivo human sensor system to generate real-time data on the levels of various body chemistries. Its first application being a glucose monitoring system. The company was founded by William McMillan, Kristen Lloyd Helton and Natalie Ann Wisniewski in 2009 and is headquartered in San Francisco, CA.

Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA.

Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX.

Beijing Kaiwu Investment Management Co. Ltd. is the private equity and venture capital firm. The firm was founded in 2011 and headquartered in Guangdong, China.

Beijing Sanyi Investment Management Co. Ltd. is an independent venture capital firm founded in 2015. The firm is headquartered in Beijing.

Micropoint Biotechnologies Co., Ltd. engages in the manufacture and sale of medical diagnosis, monitoring, and treatment equipment. Its business scope includes technology development, assembly production, and sale of clinical testing and analysis equipment, biochip, testing equipment, analytical instruments, and laboratory apparatus; development and sale of computer software; self-developed software. The company was founded by Ping Yi Yan on July 26, 2007 and is headquartered in Shenzhen, China.

Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China.